Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives

The antitumor drug 3-amino-1,2,4-benzotriazine-1,4-dioxide (tirapazamine, TPZ (<b>1</b>)) along with a number of newly synthesized tirapazamine derivatives (TPZs) bearing substitutions at the 3-amine position of TPZ (<b>1</b>) were estimated for their antibacterial activity a...

Full description

Bibliographic Details
Main Authors: Evelina Polmickaitė-Smirnova, Jonas Šarlauskas, Kastis Krikštopaitis, Živilė Lukšienė, Zita Staniulytė, Žilvinas Anusevičius
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/10/12/4062
_version_ 1797565470387208192
author Evelina Polmickaitė-Smirnova
Jonas Šarlauskas
Kastis Krikštopaitis
Živilė Lukšienė
Zita Staniulytė
Žilvinas Anusevičius
author_facet Evelina Polmickaitė-Smirnova
Jonas Šarlauskas
Kastis Krikštopaitis
Živilė Lukšienė
Zita Staniulytė
Žilvinas Anusevičius
author_sort Evelina Polmickaitė-Smirnova
collection DOAJ
description The antitumor drug 3-amino-1,2,4-benzotriazine-1,4-dioxide (tirapazamine, TPZ (<b>1</b>)) along with a number of newly synthesized tirapazamine derivatives (TPZs) bearing substitutions at the 3-amine position of TPZ (<b>1</b>) were estimated for their antibacterial activity against representative Gram-negative <i>Escherichia coli</i> (ATCC 25922) and <i>Salmonella enterica</i> (SL 5676), as well as Gram-positive <i>Staphylococcus aureus</i> (ATCC 25923) bacterial strains. Their activities in terms of minimum inhibitory concentrations (MICs) varied in the range of 1.1 µM (0.25 µg/mL)–413 µM (128 µg/mL). Amongst the most potent derivatives (<b>1</b>–<b>6</b>), acetyl- and methoxycarbonyl-substituted TPZs (<b>2</b> and <b>4</b>) were the strongest agents, which exhibited approximately 4–30 fold greater activities compared to those of TPZ (<b>1</b>) along with the reference drugs chloramphenicol (CAM) and nitrofurantoin (NFT). The inhibitory activities of the compounds were highly impacted by their structural features. No reliable relationships were established between activities and the electron-accepting potencies of the whole set of studied compounds, while the activities of TPZ drug (<b>1</b>) and the structurally uniform set of molecules (<b>2</b>–<b>6</b>) were found to increase with an increase in their electron-accepting potencies obtained by means of density functional theory (DFT) computation. A greater steric, lipophilic and polar nature of the substituents led to a lower activity of the compounds. The combined antibacterial <i>in vitro</i> trial gave clear evidence that TPZs coupled with the commonly utilized antibiotics ciprofloxacin (Cipro) and nitrofurantoin (NFT) could generate enhanced (suggestive of partial and virtually complete synergistic) and additive effects. The strongest effects were defined for TPZs–NFT combinations, which resulted in a notable reduction in the MICs of di-<i>N</i>-oxides. These preliminary findings suggest that the synthesized novel di-<i>N</i>-oxides might be used as sole agents or applied as antibiotic complements.
first_indexed 2024-03-10T19:12:39Z
format Article
id doaj.art-00b6d7faf6014048b796cdbce74ee316
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-10T19:12:39Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-00b6d7faf6014048b796cdbce74ee3162023-11-20T03:36:27ZengMDPI AGApplied Sciences2076-34172020-06-011012406210.3390/app10124062Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its DerivativesEvelina Polmickaitė-Smirnova0Jonas Šarlauskas1Kastis Krikštopaitis2Živilė Lukšienė3Zita Staniulytė4Žilvinas Anusevičius5Institute of Biochemistry, Life Science Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaInstitute of Biochemistry, Life Science Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaInstitute of Biochemistry, Life Science Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaInstitute of Photonics and Nanotechnology, Vilnius University, Saulėtekio av. 10, LT-10223 Vilnius, LithuaniaInstitute of Biochemistry, Life Science Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaInstitute of Biochemistry, Life Science Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaThe antitumor drug 3-amino-1,2,4-benzotriazine-1,4-dioxide (tirapazamine, TPZ (<b>1</b>)) along with a number of newly synthesized tirapazamine derivatives (TPZs) bearing substitutions at the 3-amine position of TPZ (<b>1</b>) were estimated for their antibacterial activity against representative Gram-negative <i>Escherichia coli</i> (ATCC 25922) and <i>Salmonella enterica</i> (SL 5676), as well as Gram-positive <i>Staphylococcus aureus</i> (ATCC 25923) bacterial strains. Their activities in terms of minimum inhibitory concentrations (MICs) varied in the range of 1.1 µM (0.25 µg/mL)–413 µM (128 µg/mL). Amongst the most potent derivatives (<b>1</b>–<b>6</b>), acetyl- and methoxycarbonyl-substituted TPZs (<b>2</b> and <b>4</b>) were the strongest agents, which exhibited approximately 4–30 fold greater activities compared to those of TPZ (<b>1</b>) along with the reference drugs chloramphenicol (CAM) and nitrofurantoin (NFT). The inhibitory activities of the compounds were highly impacted by their structural features. No reliable relationships were established between activities and the electron-accepting potencies of the whole set of studied compounds, while the activities of TPZ drug (<b>1</b>) and the structurally uniform set of molecules (<b>2</b>–<b>6</b>) were found to increase with an increase in their electron-accepting potencies obtained by means of density functional theory (DFT) computation. A greater steric, lipophilic and polar nature of the substituents led to a lower activity of the compounds. The combined antibacterial <i>in vitro</i> trial gave clear evidence that TPZs coupled with the commonly utilized antibiotics ciprofloxacin (Cipro) and nitrofurantoin (NFT) could generate enhanced (suggestive of partial and virtually complete synergistic) and additive effects. The strongest effects were defined for TPZs–NFT combinations, which resulted in a notable reduction in the MICs of di-<i>N</i>-oxides. These preliminary findings suggest that the synthesized novel di-<i>N</i>-oxides might be used as sole agents or applied as antibiotic complements.https://www.mdpi.com/2076-3417/10/12/4062heterocyclic di-<i>N</i>-oxides1,2,4-benzotriazine di-<i>N</i>-oxidestirapazamine (TPZ)antibacterial activityminimum inhibitory concentrations (MICs)chloramphenicol
spellingShingle Evelina Polmickaitė-Smirnova
Jonas Šarlauskas
Kastis Krikštopaitis
Živilė Lukšienė
Zita Staniulytė
Žilvinas Anusevičius
Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives
Applied Sciences
heterocyclic di-<i>N</i>-oxides
1,2,4-benzotriazine di-<i>N</i>-oxides
tirapazamine (TPZ)
antibacterial activity
minimum inhibitory concentrations (MICs)
chloramphenicol
title Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives
title_full Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives
title_fullStr Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives
title_full_unstemmed Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives
title_short Preliminary Investigation of the Antibacterial Activity of Antitumor Drug 3-Amino-1,2,4-Benzotriazine-1,4-Dioxide (Tirapazamine) and its Derivatives
title_sort preliminary investigation of the antibacterial activity of antitumor drug 3 amino 1 2 4 benzotriazine 1 4 dioxide tirapazamine and its derivatives
topic heterocyclic di-<i>N</i>-oxides
1,2,4-benzotriazine di-<i>N</i>-oxides
tirapazamine (TPZ)
antibacterial activity
minimum inhibitory concentrations (MICs)
chloramphenicol
url https://www.mdpi.com/2076-3417/10/12/4062
work_keys_str_mv AT evelinapolmickaitesmirnova preliminaryinvestigationoftheantibacterialactivityofantitumordrug3amino124benzotriazine14dioxidetirapazamineanditsderivatives
AT jonassarlauskas preliminaryinvestigationoftheantibacterialactivityofantitumordrug3amino124benzotriazine14dioxidetirapazamineanditsderivatives
AT kastiskrikstopaitis preliminaryinvestigationoftheantibacterialactivityofantitumordrug3amino124benzotriazine14dioxidetirapazamineanditsderivatives
AT zivileluksiene preliminaryinvestigationoftheantibacterialactivityofantitumordrug3amino124benzotriazine14dioxidetirapazamineanditsderivatives
AT zitastaniulyte preliminaryinvestigationoftheantibacterialactivityofantitumordrug3amino124benzotriazine14dioxidetirapazamineanditsderivatives
AT zilvinasanusevicius preliminaryinvestigationoftheantibacterialactivityofantitumordrug3amino124benzotriazine14dioxidetirapazamineanditsderivatives